ACTU
Actuate Therapeutics, Inc. Common stock · Healthcare
Bios Equity Cof, LP sold $200K of Actuate Therapeutics, Inc. Common stock
Director and 10% owner
Sold$199,992
$8.00Price
24,999Shares
−2%Stake
What ACTU did after the filing
- The stock from Wed, Aug 21 open, $8.95
- −21.7%
- S&P 500, same days
- +1.7%
Measured over 30 trading days, to the Oct 3 close.
Traded Wed, Aug 14. Filed Tue, Aug 20, 4:46 PM ET, after the close. Returns use the Aug 21 open and the Oct 3 close. Not investment advice.